Drug Trial Radar · NCT00315965
Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Jun 14, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
107
Planned (sponsor's estimate)
Start
Jul 2006
Primary completion
Not stated
Study completion Sep 2007
Sponsor
- Lead sponsor
- University Hospital TuebingenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 19, 2006
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 6 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Using a rapidly responding nitric oxide analyzer in a new developed modular lung-function-setup we are going to measure steady-state NO diffusing capacity in 107 healthy subjects (age 6-45 years). The results will be compared to those measured by using carbon monoxide single-breath estimates. We like to show that the new method is sufficient to measure exactly lung diffusion capacity in this collective.
Conditions
- Pulmonary Diffusing Capacity
Interventions
Nitric oxide, Carbon monoxide, HeliumDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- TLNOss
- TLCOsb
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University children´s hospital
Tübingen, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.